ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Mexico » Hematology Oncology

Top Hematology Oncology Prescribers in New Mexico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MOHAMED ASWAD MD

Hematology Oncology

14,811

$1.02M

567
412 are 65+

32%
patients receiving schedule two controlled substances

Avg: 17%

23%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 20%

$69
Average prescription price

Avg: $266

BISHNU RAUTH MD

Hematology Oncology

1,973

$328K

259
213 are 65+

19%
patients receiving schedule two controlled substances

Avg: 17%

16%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 20%

$166
Average prescription price

Avg: $266

EDGARD BADINE MD

Hematology Oncology

1,731

$688K

175
143 are 65+

36%
patients receiving schedule two controlled substances

Avg: 17%

7%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 20%

$397
Average prescription price

Avg: $266

MITCHELL BINDER MD

Hematology Oncology

1,141

$1M

166
151 are 65+

11%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 20%

$879
Average prescription price

Avg: $266

KENNETH SMITH MD

Hematology Oncology

1,006

$485K

154
133 are 65+

18%
patients receiving schedule two controlled substances

Avg: 17%

14%
patients receiving schedule three controlled substances

Avg: 6%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 20%

$482
Average prescription price

Avg: $266

TIMOTHY LOPEZ MD

Hematology Oncology

984

$690K

202
169 are 65+

14%
patients receiving schedule two controlled substances

Avg: 17%

8%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 20%

$702
Average prescription price

Avg: $266

DOUGLAS CLARK MD

Hematology Oncology

943

$745K

179
149 are 65+

11%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 20%

$790
Average prescription price

Avg: $266

JEFFREY NEIDHART MD

Hematology Oncology

902

$277K

136
109 are 65+

24%
patients receiving schedule two controlled substances

Avg: 17%

18%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 20%

$307
Average prescription price

Avg: $266

LEANNA SCOTT-TIMPERLEY MD

Hematology Oncology

808

$257K

172
130 are 65+

15%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 20%

$318
Average prescription price

Avg: $266

KATHRYN CHAN MD

Hematology Oncology

693

$142K

149
112 are 65+

17%
patients receiving schedule two controlled substances

Avg: 17%

10%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 20%

$205
Average prescription price

Avg: $266

KAREN LORUSSO MD

Hematology Oncology

637

$309K

146
111 are 65+

16%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 20%

$485
Average prescription price

Avg: $266

SCOTT HERBERT MD

Hematology Oncology

602

$297K

163
138 are 65+

21%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 20%

$494
Average prescription price

Avg: $266

PETER LINDBERG MD

Hematology Oncology

553

$190K

56
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 20%

$344
Average prescription price

Avg: $266

JANE KANOWITZ MD

Hematology Oncology

516

$67.1K

114
102 are 65+

15%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 20%

$130
Average prescription price

Avg: $266

AMY TARNOWER MD

Hematology Oncology

495

$47.4K

124
102 are 65+

15%
patients receiving schedule two controlled substances

Avg: 17%

10%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 20%

$96
Average prescription price

Avg: $266

FA-CHYI LEE M.D.

Hematology Oncology

405

$573K

96
58 are 65+

33%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 20%

$1415
Average prescription price

Avg: $266

WADIH ARAP M.D., PHD

Hematology Oncology

219

$417K

35
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 20%

$1906
Average prescription price

Avg: $266

ZONEDDY DAYAO MD

Hematology Oncology

169

$52.4K

41
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 20%

$310
Average prescription price

Avg: $266

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank